GeniPhys builds momentum with wound care technology
After 10 long years, the company that has developed a collagen biomaterial to help heal tissue is readying itself for its next big steps: regulatory approval and commercial launch.
Medical Research
-
Why Lilly is pouring billions into LEAP
In recent years, the pharmaceutical manufacturer has seen dizzying growth in its pipeline for a wide range of diseases. And modes of drug delivery are becoming increasingly complex.
Read More -
IU medical school lands record $243M in NIH funding in 2023
The Indianapolis-based medical school ranked 29th in the country for landing funding from the National Institutes of Health.
Read More -
AI tools are helping researchers discover new drugs more quickly
During the last nine years, the cumulative amount of AI investments across the pharma and biotech sectors has increased by almost thirtyfold, to $24.6 billion as of last December.
Read More -
Lilly stock skyrockets, raising profile of city’s life sciences sector
The pharmaceutical company has launched 20 drugs in the past decade to treat diseases from arthritis and psoriasis to diabetes and cancer. In recent months, Lilly has overtaken every competitor to become the most valuable drugmaker in the world.
Read More
Articles
New federal agency kickstarts Indiana kidney project with $44M award
Sen. Todd Young visited the 16 Tech innovation district Monday to underscore the work of a young federal agency that wants to shake up the conventional model of funding biomedical research.
IU, Indiana Biosciences Research Institute partner on new personalized medicine center
The Joint Center of Excellence for Point of Care Precision Medicine aims to develop better personalized care for patients with diabetes, cancer, Alzheimer’s disease and pediatric rare disease.
Lilly opens new 12-story, $700M R&D center in Boston
Lilly is moving about 200 scientists and researchers who had worked in nearby Cambridge, Massachusetts, to the new center, and plans to add about 300 employees.
Purdue, Lilly establish medical-focused research center
The Eli Lilly and Co. and Purdue University Research Alliance Center involves more than 50 researchers and 65 graduate students.
OneHealth designation could drive innovation in Elanco/Purdue space
State and corporate leaders believe a tech park taking shape on the western edge of downtown could be a launchpad for health sciences innovation and commercialization as part of the state’s ambitious economic development portfolio.
Chemo drug cisplatin increases risk of long-term hearing loss, IU researchers find
The study followed a group of testicular cancer survivors for an average of 14 years, revealing that 78% experience significant difficulties in everyday listening situations.
New director for IU Indy bioscience institute sets precision medicine as major goal
James Lin, a biomedical researcher who has focused on new innovations for tissue engineering and regenerative medicine, will start his new job in Indianapolis on Aug. 26.
FDA to bring lab tests under federal oversight in bid to improve accuracy, safety
The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
NICO Corp. gets big neurosurgery win, ponders company’s future
Indianapolis-based NICO recently wrapped up a large clinical trial that tested the company’s minimally invasive tools and technology for brain surgery in patients with hemorrhagic stroke. Now it faces a major decision.
IU lands $20M donation to establish lung cancer research center
The gift, announced Tuesday morning, is from local philanthropist Julie Wood, in honor of her late husband, Tom Wood, a prominent car dealer who died of lung cancer in 2010 at age 78.
‘Magic mushrooms’ research gets OK from Indiana House committee
The U.S. Food and Drug Administration designated psilocybin as a “breakthrough therapy” for treatment-resistant depression in 2018 and for major depressive disorder in 2019.
16 Tech gears up in reach for national stage
The live-work-play campus has been picked to join a new national network designed to connect researchers, entrepreneurs and investors to accelerate the development of health care products and services and speed up health care innovations.
New study says untreated mental illness in Indiana carries annual cost of $4.2B
The research published by the IU Richard M. Fairbanks School of Public Health found that one in five Indiana residents with mental illness do not receive the treatment they need.
Flu shots might lower risk of Alzheimer’s, related dementias
A number of studies have found that people receiving vaccinations for flu and several other infectious diseases appear less likely than the unvaccinated to develop dementia, although scientists aren’t sure why.
Device measures force of hands-on therapy
Researcher Terry Loghmani and two colleagues have developed a medical device they say can help physical therapists monitor the level of pressure they apply to the soft tissue of patients seeking greater mobility and pain relief.
Many long-COVID symptoms linger even after two years, new study shows
People who endured even mild cases of COVID-19 are at heightened risk two years later for lung problems, fatigue, diabetes and certain other health problems typical of long COVID, according to a new study that casts fresh light on the virus’s true toll.
Former top IU med school researcher says why he left
The IU School of Medicine scored a major coup five years ago when it recruited one of the nation’s top experts in the fast-growing field of regenerative medicine. But the University of Pittsburgh recruited him away this spring.
Long-term use of acid reflux medications linked to higher dementia risk
The study did not say the medications cause dementia, only that there was an association between using the drugs and a higher risk of developing dementia.
Riley Children’s Foundation lands $10M gift from Walther Cancer Foundation
Walther will provide a one-for-one match for donors who establish endowed children’s cancer research funds at Riley Children’s Foundation, a move that could result in at least $20 million for research of new treatments of children’s cancers.